Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 03 2024
0mins
Should l Buy ?
Source: Benzinga
Zomedica's Distribution Expansion: Zomedica Corp. has expanded its distribution partnership with Grovet, granting them exclusive rights to distribute Zomedica’s PulseVet and TRUFORMA products for equine use across 27 European countries, including major markets like Germany, France, and Spain.
Positive Market Response: Following the announcement, ZOM shares increased by 2.53%, reflecting investor confidence in the company's strategic growth in the equine veterinary market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
